Raymond James & Associates trimmed its position in SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report) by 39.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,120 shares of the company’s stock after selling 8,000 shares during the quarter. Raymond James & Associates’ holdings in SIGA Technologies were worth $64,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of SIGA. UBS Group AG grew its position in SIGA Technologies by 30.3% during the second quarter. UBS Group AG now owns 4,596 shares of the company’s stock valued at $53,000 after acquiring an additional 1,070 shares during the last quarter. Engineers Gate Manager LP grew its holdings in shares of SIGA Technologies by 14.5% in the fourth quarter. Engineers Gate Manager LP now owns 13,619 shares of the company’s stock worth $100,000 after purchasing an additional 1,726 shares during the last quarter. Rhumbline Advisers grew its holdings in shares of SIGA Technologies by 3.9% in the first quarter. Rhumbline Advisers now owns 62,925 shares of the company’s stock worth $362,000 after purchasing an additional 2,357 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in SIGA Technologies by 0.8% in the first quarter. Charles Schwab Investment Management Inc. now owns 311,278 shares of the company’s stock valued at $1,790,000 after acquiring an additional 2,563 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its holdings in SIGA Technologies by 13.1% in the third quarter. Price T Rowe Associates Inc. MD now owns 23,507 shares of the company’s stock valued at $243,000 after acquiring an additional 2,723 shares in the last quarter. 46.68% of the stock is owned by hedge funds and other institutional investors.
SIGA Technologies Trading Up 2.0 %
Shares of SIGA Technologies stock opened at $4.64 on Friday. The firm has a market capitalization of $329.86 million, a P/E ratio of -66.29 and a beta of 0.84. The business has a fifty day simple moving average of $5.37 and a two-hundred day simple moving average of $5.16. SIGA Technologies, Inc. has a 12 month low of $4.22 and a 12 month high of $7.17.
SIGA Technologies Profile
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
- Five stocks we like better than SIGA Technologies
- 3 Warren Buffett Stocks to Buy Now
- The 5 best small cap AI companies to buy now
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Cirrus Logic: A chip stock you’re going to hear a lot more about
- Following Congress Stock Trades
- Archer Aviation’s sky-high progress and short interest
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.